Dr Daniel Fuller Jones, MD | |
11 E Athens Ave Unit 308, Ardmore, PA 19003 | |
(802) 734-8052 | |
Not Available |
Full Name | Dr Daniel Fuller Jones |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 11 E Athens Ave Unit 308, Ardmore, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124284336 | NPI | - | NPPES |
1017743 | Medicaid | VT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZC0006X | Pathology - Clinical Pathology | 042.0011960 (Vermont) | Secondary |
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD433643 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Fuller Jones, MD Po Box 84, Norwich, VT 05055-0084 Ph: (802) 734-8052 | Dr Daniel Fuller Jones, MD 11 E Athens Ave Unit 308, Ardmore, PA 19003 Ph: (802) 734-8052 |
News Archive
Kinetic Concepts, Inc. announced today it has received 510(k) clearance from the Food and Drug Administration for the Prevena Incision Management System, a negative pressure wound therapy product designed for management of surgically closed incisions. KCI estimates more than three million procedures are performed each year worldwide that could benefit from treatment with the Prevena System, representing a potential global opportunity greater than $1 billion.
Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively treated patients with atrial fibrillation (AF), a rhythm-control strategy provides better short term control of the arrhythmia versus a rate-control strategy but does not translate into a reduction in the occurrence of clinical events at 1 year.
Common genetic factors that influence muscle strength in humans have been identified for the first time in a study led by researchers from the University of Cambridge and published today in Nature Communications.
A working party report released today calls for the co-ordinated management of chronic disease across primary and secondary care in the UK.
Professor Bill Cookson and Dr Miriam Moffatt, formerly at the University of Oxford, have joined Imperial's National Heart and Lung Institute to further develop the genetic research there, particularly focusing on how genes influence the development of asthma.
› Verified 7 days ago